Clinical Trial Update: Nitisinone for Type 1B Oculocutaneous Albinism [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for nitisinone in Type 1B oculocutaneous albinism (Phase 1/2) completed with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Albinism
• Oculocutaneous Albinism
• Vision Loss

Drugs mentioned

• Nitisinone (Nitisinone)

Snippet

Sponsor: National Eye Institute (NEI) | Conditions: Albinism, Vision Loss | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-11-17